SFP
MIRO

Sweet Financial Partners’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Sweet Financial Partners’s Portfolio MIRO Stock Details MIRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-139,553
Closed -$183K – 188
2023
Q3 		$183K Buy
139,553
+1,988
+1% +$2.9K 0.05% 169
2023
Q2 		$241K Buy
137,565
+2,453
+2% +$3.23K 0.06% 158
2023
Q1 		$227K Hold
135,112
– – 0.06% 163
2022
Q4 		$404K Sell
135,112
-136,056
-50% -$534K 0.12% 113
2022
Q3 		$1.19M Buy
271,168
+167,001
+160% +$539K 0.38% 39
2022
Q2 		$416K Buy
+104,167
New +$399K 0.13% 103
2022
Q1 		– Sell
-10,000
Closed -$47K – 189
2021
Q4 		$47K Buy
+10,000
New +$71K 0.02% 156

Sweet Financial Partners's MIRO Position: Q4 2023 in Review

Sweet Financial Partners sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q4 2023, closing a stake of 139,553 shares — an estimated $183K sold.

Sweet Financial Partners first reported a position in MIRO in Q4 2021 and held it in 7 quarters. The position peaked at $1.19M in Q3 2022. 0 funds tracked by Wall St. Rank hold MIRO as of Q4 2023.

  • Sweet Financial Partners reported no remaining Miromatrix Medical Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Sweet Financial Partners sold 139,553 Miromatrix Medical Inc. Common Stock shares in Q4 2023, an estimated $183K.
  • Sweet Financial Partners first reported a position in Miromatrix Medical Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • Sweet Financial Partners's Miromatrix Medical Inc. Common Stock position peaked at $1.19M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q4 2023.

Based on Sweet Financial Partners's 13F filing for Q4 2023, filed 12 Jan 2024.